WP1: We have developed atom economic stereoselective methods for the synthesis of glycosides of biological importance using organocatalysis and transition-metal catalysis particularly targeting deoxyglycosides which are important components of natural products and an area of carbohydrate chemistry which had been understudied until now when compared to the fully oxygenated counterparts (Org. Lett. 2020, 22, 1991; JOC 2020, 85, 5038; JOC 2019, 84, 2415; JACS 2017, 139, 14041; ACIE 2017, 56, 640; Org. Lett. 2017, 19, 2857; JOC 2017, 82, 407).
WP2:
We also pioneered the use of ionic-liquid based tags for chromatography-free purification and MS reaction monitoring in chemical and enzymatic oligosaccharide synthesis (ICROS) and more recently demonstrated that ITag-glycans can also be used to label live cells in metabolic oligosaccharide engineering applications (Chem. Commun. 2016, 52, 4906; Bioorg. Med. Chem. Lett. 2015, 25, 4329). The ITag-glycans can also be used to harness glycan-modifying enzymes directly in natural systems such as human milk (“Hot paper” in OBC 2017, 15, 3575) and these ionic labels are now being used for the discovery of novel enzyme activity (OBC 2019, 17, 5920; OBC 2020, 18, 3142, ACS Catal. 2020, 10, 17, 9986 and J. Am. Soc. Mass Spectrom. 2021 doi.org/10.1021/jasms.1c00084). In addition, we have developed chemoenzymatic routes to access a range of glycoside targets For example, the chemoenzymatic synthesis of 3-deoxy-3-fluoro L-fucosides (Chem. Commun., 2020, 56, 6408) and the biocatalytic synthesis of Pse5Ac7Ac containing glycosides (ACS Catal., 2020, 10, 17, 9986)
WP3:
We have developed novel functional nanomaterials for selective cell targeting, bioimaging and intracellular delivery (Nanoscale, 2018, 10, 13908; Scientific Reports, 2018, 8,12234; ACS Omega 2018, 3, 9822; Nanoscale 2016, 8, 18630; J. Mat. Chem. A. 2014, 2, 6879 and ACIE. 2014, 53, 810 (Hot Paper)). We use the novel nanoprobes for the cell nuclear targeting and photothermal ablation of cervical (HeLa) cancer cells over human dermal fibroblasts (HDF) (Nanoscale Adv. 2019, 1, 2840). More recently, we demonstrated the in planta use of glucose-functionalized fluorescent carbon dots. Uptake of these nanoparticles directly from the soil improves photosynthesis and also increases crop production by 18% in Dwarf wheat (New Phytol. 2020 DOI:10.1111/nph.16886). Further work in this area has led to the development of a simple spray-on-gene editing transformation method in planta, where the non-toxic nanomaterials can act as a fast vehicle for carrying plasmids into mature plant cells, resulting in transient plant transformation in a number of important crop species (BioRxiv 2009, doi.org/10.1101/805036 featured in Scientific American). The above work has been patented (PCT/EP2018/097143) and has led to Glaia Ltd. And CDotBio Ltd., University of Bristol spin-outs focused on the application of nanotechnologies in agriculture.
We also made important contributions towards the development of novel anticancer and antiparasitic drugs. We have developed synthetic and computational tools for the design and synthesis of small-molecules to selectively target G4 DNA over duplex DNA (Chem. Eur. J. 2017, 23, 6953; Chem. Eur. J. 2020, 26, 6224; Chem. Sci. 2021 ASAP) including photo-responsive ligands that can modulate (G4) DNA structure and activity as a therapeutic tool using light (Chem. Commun. 2020, 6224; ACIE. 2019, 131, 1).